抗小鼠CD40抗体（克隆号FGK4.5）引用文献

抗小鼠CD40单克隆抗体（克隆号FGK4.5）引用文献如下：

1. CD40 signaling restricts RNA virus replication in macrophages, leading to rapid innate immune control of acute virus infection
2. Mechanisms of CD40-dependent cDC1 licensing beyond costimulation
3. Macrophages and CD8+ T cells mediate the antitumor efficacy of combined CD40 ligation and imatinib therapy in gastrointestinal stromal tumors
4.The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets
5.Nanomaterials-Mediated Co-Stimulation of Toll-Like Receptors and CD40 for Antitumor Immunity
6.B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4
7.LUBAC Suppresses IL-21-Induced Apoptosis in CD40-Activated Murine B Cells and Promotes Germinal Center B Cell Survival and the T-Dependent Antibody Response
8.Anti-CD40 Monoclonal Antibody Synergizes with CTLA-4 Ig in Promoting Long-Term Graft Survival in Murine Models of Transplantation1
9.Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
10.Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer
11.Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells
12.CD4 T cell help via B cells is required for lymphopenia-induced CD8 T cell proliferation
13.Augmented interleukin (IL) -15Rα expression by CD40 activation is critical in synergistic CD8 T-cell mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice
14.Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
15.NFAM1 Promotes Pro-Inflammatory Cytokine Production in Mouse and Human Monocytes
16.Innate CD8αα+ lymphocytes enhance anti‐CD40 antibody‐mediated colitis in mice
17.Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model
18.Multimodal intralesional therapy for reshaping the myeloid compartment of tumors resistant to anti-PD-L1 therapy via IRF8
19.SAP modulates B cell functions in a genetic background-dependent manner
20.Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy
……

Syd Labs抗小鼠CD40重组抗体（克隆号FGK4.5）：

Syd Labs 重组抗小鼠CD40单克隆抗体(克隆号FGK4.5) ，大鼠IgG2a Kappa，体内实验级（ In Vivo Grade Recombinant Anti-mouse CD40 Monoclonal Antibody（Clone FGK4.5）,Rat IgG2a kappa，货号：PA007274.r2a）是用哺乳动物细胞生产的重组抗体，可用于ELISA，流式细胞术（FC），中和（neutralization），功能测定如生物分析 PK 和 ADA 测定，以及那些用于研究受小鼠CD40蛋白影响的生物学途径的测定。

如果需要了解更多有关Syd Labs 重组抗小鼠CD40单抗(克隆号FGK4.5)信息，比如Syd Labs 抗小鼠CD40单抗使用说明等资料，欢迎联系多找找获取。

特此声明：多找找推广的所有产品和服务的价格、货期和规格等信息如有更改，恕不另行通知。除非另有说明，多找找推广的所有目录和定制产品仅限于科研使用，不得用于人类或动物的诊断或治疗。